A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
Status:
Terminated
Trial end date:
2018-10-31
Target enrollment:
Participant gender:
Summary
The objective of this trial is to determine the effect of linaclotide on abdominal girth in
irritable bowel syndrome with constipation (IBS-C) participants with the baseline symptoms of
abdominal bloating and an increased abdominal girth.
Phase:
Phase 4
Details
Lead Sponsor:
Ironwood Pharmaceuticals, Inc.
Collaborators:
Manchester University NHS Foundation Trust University Hospital of South Manchester NHS Foundation Trust